Weekly Digest – 18-24 Mar 2023 Weekly Digest – 18-24 Mar 2023 March 23, 2023: Dupixent (Dupilumab, SC)/ COPD/ Sanofi: Demonstrated significant reduction in acute exacerbation in the pivotal trial Phase 3 trial comparing Dupixent to a placebo in adults […]
Weekly Digest – 18-24 Mar 2023 Weekly Digest – 18-24 Mar 2023 March 22, 2023: Elecsys (Elecsys Amyloid Plasma Panel) / Alzheimer’s disease / Roche / Lilly: Collaboration to enhance the early detection of Alzheimer’s disease Eli Lilly and Roche […]
Weekly Digest – 18-24 Mar 2023 Weekly Digest – 18-24 Mar 2023 March 22, 2023: Zynyz (Retifanlimab, IV)/ Merkel Cell Carcinoma/ Incyte Corporation: Zynyz Received US FDA approval Incyte announced US FDA approval for Zynyz for the treatment of adults […]
Weekly Digest – 18-24 Mar 2023 Weekly Digest – 18-24 Mar 2023 March 21, 2023: Yescarta / R/R Large B-cell Lymphoma / KITE’S: Yescarta (CAR T-cell Therapy) improves overall survival for R/R Large B-cell Lymphoma patients Encouraging OS data reported […]
Weekly Digest – 18-24 Mar 2023 Weekly Digest – 18-24 Mar 2023 March 21, 2023: Ulenistamab (PBP1510) (IV)/ Pancreatic Cancer/ Prestige Biopharma: US FDA granted fast track designation Prestige Biopharma received a fast-track designation from the US FDA for PBP1510 […]
Weekly Digest – 18-24 Mar 2023 Weekly Digest – 18-24 Mar 2023 March 20, 2023: ONC-392 (IV)/ Solid tumors/ BioNTech & OncoC4: Announced a collaboration to co-develop & commercialize a novel checkpoint antibody BioNTech and OncoC4 collaborated to co-develop and […]
